1. JAM-A and ALCAM are therapeutic targets to inhibit diapedesis across the BBB of CD14+CD16+ monocytes in HIV-infected individuals. Issue 2 (24th November 2014) Authors: Williams, Dionna W; Anastos, Kathryn; Morgello, Susan; Berman, Joan W Journal: Journal of leukocyte biology Issue: Volume 97:Issue 2(2015) Page Start: 401 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. JAM‐A and ALCAM are therapeutic targets to inhibit diapedesis across the BBB of CD14+CD16+ monocytes in HIV‐infected individuals. Issue 2 (24th November 2014) Authors: Williams, Dionna W.; Anastos, Kathryn; Morgello, Susan; Berman, Joan W. Journal: Journal of leukocyte biology Issue: Volume 97:Issue 2(2015) Page Start: 401 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗